Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Progyny, Inc. (PGNY) Cash Flow Statement

Progyny, Inc. (PGNY) generated $201.2M of operating cash flow over the twelve months to 2026-06-30, spent $22.9M on capital expenditure and had free cash flow of $178.4M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

PGNYProgyny, Inc.Follow PGNY — free
Healthcare Plans · Healthcare
—
Price chart with a free account
Market cap
2.2B
P/E TTM
31.5
Dividend yield
—
52-week
—
Next earnings
4 Nov, in 11 days
LineFY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow-0.000.040.030.080.190.180.210.20
Capital expenditure0.000.000.000.000.000.010.02-0.02
Free cash flow-0.000.040.020.080.190.170.190.18
Share repurchases0.00——0.000.000.300.08—
Stock-based compensation0.010.010.030.100.120.130.13—

USD billions · SEC XBRL

Progyny, Inc. — questions

What is Progyny, Inc.'s operating cash flow?
$201.2M over the twelve months to 2026-06-30.
How much does Progyny, Inc. spend on capital expenditure?
$22.9M over the twelve months to 2026-06-30.
What is Progyny, Inc.'s free cash flow?
$178.4M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from Progyny, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.